How Can We Distinguish Sorafenib-Associated Skin Rash From Skin Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation?
J Clin Oncol
.
2021 Apr 20;39(12):1412.
doi: 10.1200/JCO.20.02228.
Epub 2021 Feb 23.
Author
Shigeo Fuji
1
Affiliation
1
Shigeo Fuji, MD, PhD, Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
PMID:
33621112
DOI:
10.1200/JCO.20.02228
No abstract available
Publication types
Letter
Comment
MeSH terms
Exanthema* / chemically induced
Exanthema* / diagnosis
Graft vs Host Disease* / diagnosis
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Sorafenib / adverse effects
Transplantation, Homologous
Substances
Sorafenib